{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T14:38:52Z","timestamp":1772030332655,"version":"3.50.1"},"reference-count":34,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T00:00:00Z","timestamp":1771977600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Hebei Government-Funded Program for Clinical Medicine Talents","award":["ZF2025230"],"award-info":[{"award-number":["ZF2025230"]}]},{"name":"Medical Science Research Project of Hebei","award":["20241729"],"award-info":[{"award-number":["20241729"]}]},{"name":"Medical Science Research Project of Hebei","award":["20230124"],"award-info":[{"award-number":["20230124"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Oncology"],"abstract":"<jats:p>Background: Pediatric non-Hodgkin lymphoma (NHL) is a heterogeneous malignancy with variable outcomes. Adenosine deaminase (ADA), a key enzyme in purine metabolism, has been implicated in tumor progression and immune evasion, yet its role in pediatric NHL remains underexplored. Methods: This retrospective study included 215 pediatric NHL patients categorized into precursor cell lymphoma (n = 88) and mature cell lymphoma (n = 127) groups based on pathology. Patients were further defined into good (n = 143) and poor prognosis (n = 72) groups according to international response criteria. Serum ADA and other laboratory parameters were measured at diagnosis. Results: Precursor cell lymphomas showed higher rates of bone marrow involvement, peripheral blood involvement, and clinical stage IV disease compared to mature cell lymphomas. ADA levels were significantly elevated in precursor cell lymphomas and in the poor prognosis group. Elevated ADA was strongly correlated with a poor prognosis. Multivariable analysis identified precursor cell lymphoma, fever, bone marrow involvement, elevated LDH, and elevated ADA as independent predictors of poor prognosis (all p &lt; 0.05). Conclusions: Serum ADA is significantly elevated in pediatric NHL, particularly in precursor cell subtypes and poor prognosis cases, and serves as a potential prognostic marker. ADA may help improve risk stratification and guide personalized treatment strategies.<\/jats:p>","DOI":"10.3390\/curroncol33030134","type":"journal-article","created":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T12:35:17Z","timestamp":1772022917000},"page":"134","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Expression of Serum Adenosine Deaminase in Pediatric Non-Hodgkin Lymphoma and Its Association with Clinical Outcomes and Survival"],"prefix":"10.3390","volume":"33","author":[{"given":"Xiuli","family":"Zhu","sequence":"first","affiliation":[{"name":"Department of Pediatrics, The Fourth Hospital of Hebei Medical University, Shijiazhuang 050011, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuqiao","family":"Diao","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, The Fourth Hospital of Hebei Medical University, Shijiazhuang 050011, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, The Fourth Hospital of Hebei Medical University, Shijiazhuang 050011, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2026,2,25]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1053\/j.semdp.2023.06.002","article-title":"Aggressive non-Hodgkin lymphoma in the pediatric and young adult population; diagnostic and molecular pearls of wisdom","volume":"40","author":"Singh","year":"2023","journal-title":"Semin. Diagn. Pathol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.21873\/invivo.13761","article-title":"Pediatric B-cell Non-Hodgkin Lymphoma: The Impact of Therapy Response and Relapse on Outcome. A Single-center Analysis","volume":"38","author":"Stankiewicz","year":"2024","journal-title":"In Vivo"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Ostojska, M., Nowak, E., Twardowska, J., Lejman, M., and Zawitkowska, J. (2023). CAR-T Cell Therapy in the Treatment of Pediatric Non-Hodgkin Lymphoma. J. Pers. Med., 13.","DOI":"10.3390\/jpm13111595"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"ytad305","DOI":"10.1093\/ehjcr\/ytad305","article-title":"Where has the lymphoma gone? Pericardial effusion adenosine deaminase may play a key role in diagnosing primary effusion lymphoma-like lymphoma: A case report","volume":"7","author":"Fujimoto","year":"2023","journal-title":"Eur. Heart J. Case Rep."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Zhulai, G., Oleinik, E., Shibaev, M., and Ignatev, K. (2022). Adenosine-Metabolizing Enzymes, Adenosine Kinase and Adenosine Deaminase, in Cancer. Biomolecules, 12.","DOI":"10.3390\/biom12030418"},{"key":"ref_6","first-page":"001633","article-title":"Elevated Adenosine Deaminase in Pleural Effusion A Case of Non-Hodgkin Lymphoma Misdiagnosis","volume":"7","author":"Seco","year":"2020","journal-title":"Eur. J. Case Rep. Intern. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1093\/jleuko\/qiad094","article-title":"A new hope for early T cell precursor acute lymphoblastic leukemia therapy based on STAT5+ leukemic stem cell targeting","volume":"114","author":"Pelayo","year":"2023","journal-title":"J. Leukoc. Biol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e746","DOI":"10.1097\/MPH.0000000000002656","article-title":"Precursor B-cell Lymphoblastic Lymphoma in Children: Hacettepe Experience","volume":"45","author":"Yalcin","year":"2023","journal-title":"J. Pediatr. Hematol.\/Oncol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"113361","DOI":"10.1016\/j.intimp.2024.113361","article-title":"Sphingosine kinase 1 counteracts chemosensitivity and immune evasion in diffuse large B cell lymphoma cells via the PI3K\/AKT\/PD-L1 axis","volume":"143","author":"Liu","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1007\/s00428-023-03520-x","article-title":"Immune evasion phenotype is common in Richter transformation diffuse large B-cell lymphoma variant","volume":"482","author":"Medeiros","year":"2023","journal-title":"Virchows Arch. Int. J. Pathol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"e70038","DOI":"10.1111\/sji.70038","article-title":"Adenosine and Adenosine Deaminase Contrary Manifestations in Immunity","volume":"102","author":"Mardanyan","year":"2025","journal-title":"Scand. J. Immunol."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Lin, L., Roccuzzo, G., Yakymiv, Y., Marchisio, S., Ortolan, E., Funaro, A., Senetta, R., Pala, V., Bagot, M., and de Masson, A. (2025). The CD39\/CD73\/Adenosine and NAD\/CD38\/CD203a\/CD73 Axis in Cutaneous T-Cell Lymphomas. Cells, 14.","DOI":"10.3390\/cells14040309"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2293514","DOI":"10.1080\/16078454.2023.2293514","article-title":"Prognostic value of lactate dehydrogenase, serum albumin and the lactate dehydrogenase\/albumin ratio in patients with diffuse large B-cell lymphoma","volume":"29","author":"Wu","year":"2024","journal-title":"Hematology"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Li, N., Feng, Y., Chen, X., and Zou, L.Q. (2025). The prognostic value of lactate dehydrogenase\/albumin ratio in extranodal natural killer\/T cell lymphoma. BMC Cancer, 25.","DOI":"10.1186\/s12885-025-14393-5"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"110905","DOI":"10.1016\/j.isci.2024.110905","article-title":"The prognostic value of hydroxybutyrate dehydrogenase in diffuse large B cell lymphoma","volume":"27","author":"Zhang","year":"2024","journal-title":"iScience"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"289","DOI":"10.21147\/j.issn.1000-9604.2021.03.01","article-title":"Chinese Society of Clinical Oncology (CSCO) diagnosis and treatment guidelines for malignant lymphoma 2021 (English version)","volume":"33","author":"Zhu","year":"2021","journal-title":"Chin. J. Cancer Res."},{"key":"ref_17","unstructured":"Subspecialty Group of Hematology, the Society of Pediatrics, Chinese Medical Association, Pediatric Oncology Committee, Chinese Anticancer Association, and Editorial Board of Chinese Journal of Pediatrics (2011). [Recommendation for pediatric non-Hodgkin\u2019s lymphoma]. Chin. J. Pediatr., 49, 186\u2013192."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1200\/JCO.2014.59.0745","article-title":"International Pediatric Non-Hodgkin Lymphoma Response Criteria","volume":"33","author":"Sandlund","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"101440","DOI":"10.1016\/j.beha.2023.101440","article-title":"Diagnosis and management of rare paediatric Non-Hodgkin lymphoma","volume":"36","author":"Xavier","year":"2023","journal-title":"Best Pract. Res. Clin. Haematol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s00428-023-03590-x","article-title":"Emerging entities: High-grade\/large B-cell lymphoma with 11q aberration, large B-cell lymphoma with IRF4 rearrangement, and new molecular subgroups in large B-cell lymphomas. A report of the 2022 EA4HP\/SH lymphoma workshop","volume":"483","author":"Laurent","year":"2023","journal-title":"Virchows Arch. Int. J. Pathol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1111\/bjh.20011","article-title":"Clinical and molecular characteristics of paediatric mature B-cell acute lymphocytic leukaemia and non-Hodgkin lymphoma with bone marrow involvement: A joint study between the CCCG leukaemia and lymphoma groups","volume":"206","author":"Zhao","year":"2025","journal-title":"Br. J. Haematol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1038\/s41409-025-02563-9","article-title":"Bone marrow versus peripheral blood stem cells as the graft source for allogeneic transplantation from HLA-matched relative donors in adult T-cell leukemia\/lymphoma: A nationwide retrospective study by the ATL working group of the Japanese Society for Transplantation and Cellular Therapy","volume":"60","author":"Itonaga","year":"2025","journal-title":"Bone Marrow Transplant."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms","volume":"36","author":"Alaggio","year":"2022","journal-title":"Leukemia"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1038\/s41591-025-03499-9","article-title":"Multiomic profiling of T cell lymphoma after therapy with anti-BCMA CAR T cells and GPRC5D-directed bispecific antibody","volume":"31","author":"Braun","year":"2025","journal-title":"Nat. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1182\/blood.2023021787","article-title":"New insights into the biology of T-cell lymphomas","volume":"144","author":"Iqbal","year":"2024","journal-title":"Blood"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/s10875-024-01712-x","article-title":"Development of EBV Related Diffuse Large B-cell Lymphoma in Deficiency of Adenosine Deaminase 2 with Uncontrolled EBV Infection","volume":"44","author":"Gardner","year":"2024","journal-title":"J. Clin. Immunol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"e31895","DOI":"10.1002\/pbc.31895","article-title":"Circulating Tumor DNA in Pediatric Mature B-Cell Non-Hodgkin Lymphoma for Genotyping and Minimal Disease Monitoring","volume":"72","author":"Werner","year":"2025","journal-title":"Pediatr. Blood Cancer"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.21873\/invivo.13708","article-title":"Toward Inclusive Oncology: Challenges in the Therapy of Pediatric Non-B Non-Hodgkin Lymphomas","volume":"38","author":"Stankiewicz","year":"2024","journal-title":"In Vivo"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/ejh.14148","article-title":"Rituximab with standard LMB chemotherapy in pediatric high-risk mature B-cell non-Hodgkin lymphoma: A report from the JPLSG B-NHL14 trial","volume":"112","author":"Mori","year":"2024","journal-title":"Eur. J. Haematol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"6381","DOI":"10.1182\/bloodadvances.2023009731","article-title":"High-grade B-cell lymphoma, not otherwise specified: A multi-institutional retrospective study","volume":"7","author":"Zayac","year":"2023","journal-title":"Blood Adv."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1002\/biof.2053","article-title":"Lactate dehydrogenase A is implicated in the pathogenesis of B-cell lymphoma through regulation of the FER signaling pathway","volume":"50","author":"Feng","year":"2024","journal-title":"BioFactors"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1007\/s10238-024-01402-3","article-title":"Survival trend and outcome prediction for pediatric Hodgkin and non-Hodgkin lymphomas based on machine learning","volume":"24","author":"Zheng","year":"2024","journal-title":"Clin. Exp. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"e757","DOI":"10.1097\/MPH.0000000000002699","article-title":"Prognostic Factors and Treatment Outcome of Relapsing and Refractory Pediatric Mature B-cell Non-Hodgkin Lymphoma, Children\u2019s Cancer Hospital Egypt Experience","volume":"45","author":"Semary","year":"2023","journal-title":"J. Pediatr. Hematol.\/Oncol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.47391\/JPMA.6901","article-title":"Clinical Characteristics And Treatment Outcome of Paediatric Non-Hodgkin\u2019s Lymphoma at A Tertiary Care Hospital In Pakistan","volume":"73","author":"Naqvi","year":"2023","journal-title":"J. Pak. Med. Assoc."}],"container-title":["Current Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1718-7729\/33\/3\/134\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T13:18:35Z","timestamp":1772025515000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1718-7729\/33\/3\/134"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,25]]},"references-count":34,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["curroncol33030134"],"URL":"https:\/\/doi.org\/10.3390\/curroncol33030134","relation":{},"ISSN":["1718-7729"],"issn-type":[{"value":"1718-7729","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,25]]}}}